Resource Center

PRA Health Sciences to Present with ArcheMedX at Clinical Trial Innovations Summit 2020

ArcheMedX today announced its on-going collaboration with PRA Health Sciences in a highly anticipated joint case study at the 2020 Clinical Trial Innovations Summit.

On Wednesday, 11 November, Kelly Ritch, EVP of Product and Clinical Solutions at ArcheMedX, will join Susan Zakarian, Sr. Manager of PRA Health Sciences to co-present a session titled:  How PRA Health Sciences Virtualized Clinical Operations Performance Management.

This session will explore how PRA Health Sciences continues to transform performance management across clinical operations by embracing a virtualized approach that identifies leading indicators of readiness to predict and improve performance in the field. PRA Health Sciences chose to partner with ArcheMedX in order to: 

  • Better understand team members’ actual capabilities and potential to grow in their role
  • Help managers more accurately identify and focus on team members’ areas of demonstrated need 
  • Reduce workload by replacing time consuming evaluations with a standardized, data-enabled solution
  • Streamline and automate individual remediation and upskilling

In the discussion, Ms. Ritch and Ms. Zakarian will reveal how PRA built the business case for this undertaking, the process they used, and the outcomes they’ve realized from the on-going success.

The Summit for Clinical Trials Operations Executives Europe (SCOPE Europe) and Clinical Trial Innovation Summit have become a combined two-day event serving clinical innovation leaders, clinical operations executives, functional heads, category managers, and those responsible for the planning and management of clinical trials in Europe and the Rest of the World.

The event features 8 keynote presentation and panel sessions, five conference tracks, interactive breakout discussion groups, and networking.

[Updated] You can now access the final presentation on-demand: https://www.info.archemedx.com/virtualize-clinical-operations-performance-management

New call-to-action

Avatar

Written by

Molly has spent her entire career in high tech. More than half of that time she has focused on bringing marketing solutions and launching new products in the life sciences industry, particularly in clinical, research, and commercialization of treatments.